Literature DB >> 4951928

Hemophilia prophylaxis with factor VIII concentrate.

C K Kasper, S L Dietrich, S I Rapaport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4951928

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.

Authors:  Margaret V Ragni
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

Review 2.  Current transfusion therapy.

Authors:  E Hinkes; R O Steffen
Journal:  Calif Med       Date:  1973-05

3.  [Hemolysins and isoagglutinins in substitute preparations containing factor VIII].

Authors:  U Göbel; M Ranke
Journal:  Blut       Date:  1972-06

Review 4.  Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.

Authors:  S Björkman; E Berntorp
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 5.  Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.

Authors:  Hans-Christoph Rossbach
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

6.  Haemophilia A home therapy in the United Kingdom 1975-6.

Authors:  P Jones; M Fearns; C Forbes; J Stuart
Journal:  Br Med J       Date:  1978-06-03

Review 7.  Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.

Authors:  Erik Berntorp; Gerald Spotts; Lisa Patrone; Bruce M Ewenstein
Journal:  Biologics       Date:  2014-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.